What is the Kernel device used for in the experiment?

The Kernel is a brain monitoring device that measures oxygen levels in the brain to map activity. It's used to assess brain health and identify signatures related to drug interactions or different mental states.

How does psilocybin affect inhibitions during the experience?

During a psilocybin experience, inhibitions can be significantly reduced, leading to less internal filtering of thoughts and speech. This can result in saying or thinking things that might normally be suppressed.

What are the potential longevity benefits of psilocybin?

Preclinical trials suggest psilocybin may reverse biologic aging in human cells. The experiment explores if it can help healthy people live more productive and meaningful lives by impacting gene expression and potentially rejuvenating cells.

What is T-max in the context of psilocybin dosage?

T-max refers to the time it takes to reach the highest concentration of psilocin in the blood plasma after oral ingestion of psilocybin. This typically occurs between 1.5 to 2 hours after consumption.

How are psychedelics currently classified in the US?

Currently, most major psychedelic drugs are classified as Schedule I controlled substances in the United States. This classification means they are considered to have no medical value, although research is ongoing to potentially reclassify compounds like MDMA and psilocybin.

What is the connection between psychedelics and epigenetics?

Studies suggest that certain psychedelic compounds can change gene expression profiles, potentially leading to cellular rejuvenation. This is linked to the epigenome, which influences aging and cellular function.

What is the significance of the spiritual and religious aspects of psychedelics?

There's a perceived connection between spiritual or religious practices and the experiences induced by psychedelics. Researchers are exploring bridges between these domains and scientific understanding, suggesting that psychedelics might offer a 'cheat code' to achieving deep states often sought through years of meditation.

I Tried Psilocybin for Science (Livestream Highlights)

Bryan Johnson

Education4 min read26 min video

Dec 11, 2025|213,370 views|6,803|923

Bryan Johnson Brian Johnson Blueprint Longevity Anti-Aging Anti-Ageing Don't Die Grimes Mushrooms Shrooms Kate Tolo

Save to Pod

Key Moments

TL;DR

Bryan Johnson experiments with psilocybin for longevity, measuring biomarkers and experiencing altered consciousness.

Key Insights

Psilocybin is being explored as a potential longevity therapy, with early preclinical trials showing it can reverse biological aging in human cells.

Bryan Johnson's experiment is highly quantified, measuring 249 biomarkers, making it potentially the most comprehensive psychedelic experiment to date.

The experiment investigates psilocybin's effects on brain activity using advanced technology like kernel, which maps brain regions and signatures of drug interactions.

Participants report altered states of consciousness, including enhanced sensory perception, faster thought processing, and a sense of interconnectedness.

The research aims to shift the conversation around psychedelics, moving beyond psychiatric disorders to explore their potential benefits for healthy individuals seeking more productive lives.

There's a growing understanding of how molecules in psychedelics might reset the 'epigenome,' potentially leading to cellular rejuvenation and a reversal of aging effects.

EXPLORING PSYLOCYBIN AS A LONGEVITY THERAPY

Bryan Johnson is conducting a unique experiment to investigate whether psilocybin can serve as a longevity therapy. This involves taking significant doses of psilocybin and meticulously measuring a wide array of biomarkers. The experiment is notable for its high degree of quantification, aiming to capture 249 biomarkers, positioning it as potentially the most data-rich psychedelic study ever performed. The ultimate goal is to determine if compounds like psilocybin can contribute to slowing or even reversing the aging process.

ADVANCED BIOMARKER MEASUREMENT AND BRAIN MAPPING

The research employs sophisticated technology, including a device called 'kernel,' designed to measure oxygen levels in the brain. This allows for the mapping of active brain regions, offering insights into brain health and the neurological signatures of drug interactions and various mental states. Alongside this, the protocol includes a comprehensive suite of measurements such as saliva tests, thermal body heat readings, and blood pressure monitoring, providing a holistic baseline and ongoing assessment of physiological and neurological responses.

THE PSYCHEDELIC EXPERIENCE AND ALTERED CONSCIOUSNESS

During the psilocybin experience, participants describe profound shifts in consciousness. These include a noticeable reduction in inhibitions, leading to faster and less filtered thought processes, and a heightened perception of the environment. Sensations reported involve the body feeling nimble and loose, rooms pulsating, and a feeling of everything being alive. Visuals become intensely vivid, with colors appearing more vibrant, and a general sense of awe and wonder at the altered sensory input is common.

FAMILY AND FRIEND PARTICIPATION AND SUPPORT

The experiment includes the participation of close family members and friends, notably Bryan Johnson's son, Talmage, and writer Ashley Vance. Their presence offers a layer of emotional support and observation, providing unique perspectives on Bryan's experience. Talmage's involvement highlights a blend of parental and childlike roles, with deep affection and a sense of profound connection being expressed. This adds a personal dimension to the scientific endeavor, emphasizing the human aspect of exploring consciousness.

SCIENTIFIC AND MEDICAL IMPLICATIONS OF PSYLOCYBIN

Discussions with medical professionals like Dr. Carl Seager highlight the scientific rationale behind exploring psilocybin. Preclinical studies suggest its potential to reverse biological aging at the cellular level. Researchers are investigating its capacity to open critical periods in the brain, aiding in recovery from conditions like stroke. The legal status of psilocybin as a Schedule I substance in the US is acknowledged, with a hope that ongoing medical research can lead to reclassification and medical prescription eligibility for compounds like psilocybin and MDMA.

EPIGENETIC REJUVENATION AND SPIRITUAL CONNECTION

A key area of scientific interest is the potential for psilocybin to influence the epigenome, the system that controls gene expression. Emerging research suggests that compounds found in these mushrooms may reset the epigenome, leading to cellular rejuvenation and counteracting age-related dysfunction. Beyond the biological, the spiritual and religious aspects of psychedelic experiences are also explored, with connections drawn between meditation practices and the profound, often spiritual, states induced by these substances, suggesting a bridge between ancient wisdom and modern science.

DEMISTIFYING PSYCHEDELICS AND SHIFTING CONVERSATIONS

The experiment is framed within a broader effort to demystify psychedelics and broaden public and scientific discourse. By openly documenting such a high-dose, biomarker-focused exploration, the aim is to move the conversation beyond solely focusing on psychological disorders. The hope is to illustrate how these substances might help otherwise healthy individuals live more meaningful, productive, and enhanced lives. This approach is seen as crucial for 'busting open the Overton window' on discussions and research into these powerful compounds.

PEAK EXPERIENCE AND POST-EXPERIENCE MEASUREMENTS

As Bryan Johnson reaches the peak of his experience, further measurements are taken, including saliva samples and reaction time tests, even amidst his altered state. These moments, though challenging, are critical for capturing data at the height of the psilocybin's effects. His interactions during this phase reveal a profound sense of joy, love, and connection, particularly with his son, highlighting the emotional and interpersonal impacts of the powerful psychedelic journey, underscoring the multifaceted nature of the research.

Mentioned in This Episode

●Supplements

●Software & Apps

●Organizations

●Concepts

●People Referenced

Common Questions

The experiment investigates whether psilocybin can act as a longevity therapy by potentially slowing down aging and reversing age-related damage. It aims to measure 249 biomarkers, making it the most quantified psychedelic experiment in history.

Topics

Psychedelic Research Spiritual Experiences Ibogaine Self-experimentation Biomarkers

Mentioned in this video

personGul Dolan

A researcher at Berkeley with a theory that psychedelics work by opening critical periods, currently testing this hypothesis with stroke victims and psilocybin.

softwareKernel

A device developed by Ryan Fields that functions as a 'pulse oximeter on steroids', measuring oxygen in the brain to map brain activity and assess brain health.

personCarl Seager

Longevity physician helping with the psilocybin protocol experiment. He notes preclinical trials showing psilocybin can reverse biologic aging.

personAshley Vance

Writer whose article about Blueprint blew up, contributing to the platform's visibility.

otherBlueprint

A platform or project that Brian and Ashley Vance started, which gained significant attention after an article was published.